Prevalence of Sero-Molecular Markers of Hepatitis C and B Viruses among Patients with β-Thalassemia Major in Northern West Bank, Palestine

Table 3

Clinical and laboratory parameters of the study group.

Parameter	Mean ± SD
Hb (g/dl)	7.9 ± 1.04
MCV (fl)	75.05 ± 10.82
AST (U/L)	55.4 ± 28.7
ALT (U/L)	46.2 ± 29.4
ALP (U/ml)	334.7 ± 201.5
Anti-HBs (U/ml)	271.8 ± 390.9
	N (%)
Anti-HBs ≤ 10 IU/ml	40 (28.8)
Anti-HBc +ve	25 (19)
Total HCV +ve	14 (10)
Anti-HCV +ve	7 (5)
Anti-HCV +ve and HCV-RNA +ve	4 (2.9)
Anti-HCV +ve and HCV-RNA −ve	3 (2.1)
Anti-HCV −ve and HCV-RNA +ve	7 (5.3)
Anti-HCV −ve and HCV-RNA −ve	126 (90)
History of jaundice	44 (32)
Dental procedure	71 (52)
Splenectomy	59 (82)

Hb: hemoglogin; MCV: mean corpuscular volume; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase.